Liver Cancer News and Research

RSS
Liver cancer is more common in older people. Over half of people newly diagnosed with liver cancer are age 65 and over. Liver cancer is more common in men than in women. Liver cancer rates are highest among Asians and Pacific Islanders, most likely because of higher prevalence of viral Hepatitis infection. Liver cancer rates are lower among whites than Blacks or Asians and Pacific Islanders. At this time, we do not know exactly what causes cancer of the liver. There are several different types of liver cancer. The most common type is associated with long-term excessive alcoholic beverage use, scarring of the liver (cirrhosis), and Hepatitis B virus or Hepatitis C virus infection. Long-term use of anabolic steroids can also increase the risk of getting liver cancer. Smoking is also believed to increase the risk of getting liver cancer.
Scientists show how sorafenib can be dangerous to the heart

Scientists show how sorafenib can be dangerous to the heart

SCYNEXIS announces results from SCY-635 Phase 2a study on HCV

SCYNEXIS announces results from SCY-635 Phase 2a study on HCV

UC Irvine, Cal State Fullerton partner to help reduce cancer disparities in Orange County

UC Irvine, Cal State Fullerton partner to help reduce cancer disparities in Orange County

Nitisinone treatment effectively prevents tyrosinemia in children

Nitisinone treatment effectively prevents tyrosinemia in children

BioCryst announces withdrawal of BCX5191 IND following discussion with FDA

BioCryst announces withdrawal of BCX5191 IND following discussion with FDA

Chemists' innovation may be a better model for disease diagnostic kits

Chemists' innovation may be a better model for disease diagnostic kits

Antiviral therapy cuts progression to cancer in hepatitis

Antiviral therapy cuts progression to cancer in hepatitis

BioLineRx completes pre-clinical development of BL-8020 for HCV

BioLineRx completes pre-clinical development of BL-8020 for HCV

Statins could be first preventive treatment for liver cancer

Statins could be first preventive treatment for liver cancer

Scientists look to use natural killer cells to target common form of liver cancer

Scientists look to use natural killer cells to target common form of liver cancer

Researchers decipher how AP-1 gene regulator controls survival of liver tumor-initiating cells

Researchers decipher how AP-1 gene regulator controls survival of liver tumor-initiating cells

Provectus amends and expands protocol for PV-10 Phase 1 hepatocellular carcinoma study

Provectus amends and expands protocol for PV-10 Phase 1 hepatocellular carcinoma study

LIFR protein suppresses local invasion and metastasis of breast cancer cells

LIFR protein suppresses local invasion and metastasis of breast cancer cells

BioAlliance, Vestiq enter licensing agreement to commercialize Oravig in the US

BioAlliance, Vestiq enter licensing agreement to commercialize Oravig in the US

RRM2 may be a facilitating factor in colorectal cancer and UV-induced DNA damage repair

RRM2 may be a facilitating factor in colorectal cancer and UV-induced DNA damage repair

Jennerex Phase 2 JX-594 clinical data for hepatocellular carcinoma presented at ILCA meeting

Jennerex Phase 2 JX-594 clinical data for hepatocellular carcinoma presented at ILCA meeting

Exercise, good nutrition play a crucial role in maintaining health and fighting disease

Exercise, good nutrition play a crucial role in maintaining health and fighting disease

Telaprevir offers advantages in patients with chronic hepatitis C infection of genotype 1

Telaprevir offers advantages in patients with chronic hepatitis C infection of genotype 1

Personalized colon cancer therapy based on genetics of specific cancer

Personalized colon cancer therapy based on genetics of specific cancer

One blog examines GAVI Alliance's efforts to accelerate introduction of hepatitis B vaccines in developing countries

One blog examines GAVI Alliance's efforts to accelerate introduction of hepatitis B vaccines in developing countries

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.